Provided by Tiger Trade Technology Pte. Ltd.

Ascendis Pharma A/S

229.23
+6.542.94%
Post-market: 229.230.00000.00%16:12 EDT
Volume:760.99K
Turnover:174.34M
Market Cap:15.17B
PE:17.47
High:233.96
Open:225.08
Low:223.96
Close:222.69
52wk High:282.15
52wk Low:186.05
Shares:66.19M
Float Shares:65.54M
Volume Ratio:0.89
T/O Rate:1.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):13.12
EPS(LYR):-4.4176
ROE:118.78%
ROA:9.58%
PB:9.43
PE(LYR):-51.89

Loading ...

Ascendis Announces Oral Presentation of Week 104 Data from Its Pivotal Trial of Transcon® Cnp (Navepegritide) at Isds 2026

THOMSON REUTERS
·
Aug 26

Ascendis Pharma (ASND) On Profitability, The Valuation Narrative Still Points To Upside

Simply Wall St.
·
Aug 25

Ascendis Pharma Director Jean-Jacques Bienaime Buys USD 492,079 of Common Shares

Reuters
·
Aug 19

Eyconis Announces Initiation of First-in-Human Clinical Trial of Eyc-0305 in Treatment-NaÏVe Wet Age-Related Macular Degeneration Patients

THOMSON REUTERS
·
Aug 18

Ascendis Pharma A/S Just Recorded A 104% EPS Beat: Here's What Analysts Are Forecasting Next

Simply Wall St.
·
Aug 16

Ascendis Pharma Reports Solid Yorvipath Quarter; Yuviwel Off to Strong Start, RBC Says

MT Newswires Live
·
Aug 14

Ascendis Pharma is Maintained at Overweight by Barclays

Dow Jones
·
Aug 14

Ascendis Pharma (ASND) Receives a Buy from Cantor Fitzgerald

TIPRANKS
·
Aug 14

RBC Adjusts PT on Ascendis Pharma to $290 From $280, Maintains Outperform Speculative Risk Rating

MT Newswires Live
·
Aug 14

Ascendis Pharma (ASND) Receives a Buy from Wells Fargo

TIPRANKS
·
Aug 14

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Ascendis Pharma (ASND)

TIPRANKS
·
Aug 14

Ascendis Pharma a/S : Jefferies Raises Target Price to $333 from $325

THOMSON REUTERS
·
Aug 14

Analysts Are Bullish on These Healthcare Stocks: ProMIS Neurosciences (PMN), Ascendis Pharma (ASND)

TIPRANKS
·
Aug 14

Ascendis Pharma's Long-Term Potential Intact, Wedbush Says

MT Newswires Live
·
Aug 14

European Equities Traded in the US Rise in Thursday Trading

MT Newswires Live
·
Aug 13

Ascendis Pharma A/S Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 13

Sector Update: Healthcare Stocks Advance Pre-Bell Thursday

MT Newswires Live
·
Aug 13

Ascendis Pharma's Q2 Adjusted Earnings, Revenue Rise

MT Newswires Live
·
Aug 13

Earnings Flash (ASND) Ascendis Pharma Posts Q2 Non-IFRS EPS 0.90 Euros, vs. FactSet Est of 1.80 Euros

MT Newswires Live
·
Aug 13

Ascendis Pharma Q2 Revenue EUR 339.3 Million

THOMSON REUTERS
·
Aug 13